Rbc Sciences Biologiques Fund Manager Performance Evaluation

0P00007138  CAD 53.20  0.03  0.06%   
The entity owns a Beta (Systematic Risk) of 0.21, which implies not very significant fluctuations relative to the market. As returns on the market increase, RBC Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding RBC Sciences is expected to be smaller as well.

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RBC sciences biologiques are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. Despite somewhat unfluctuating basic indicators, RBC Sciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
...more
Fifty Two Week Low20.01
Fifty Two Week High30.22
Annual Report Expense Ratio2.10%
  

RBC Sciences Relative Risk vs. Return Landscape

If you would invest  4,935  in RBC sciences biologiques on August 29, 2024 and sell it today you would earn a total of  385.00  from holding RBC sciences biologiques or generate 7.8% return on investment over 90 days. RBC sciences biologiques is generating 0.126% of daily returns and assumes 0.983% volatility on return distribution over the 90 days horizon. Simply put, 8% of funds are less volatile than RBC, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon RBC Sciences is expected to generate 1.0 times less return on investment than the market. In addition to that, the company is 1.27 times more volatile than its market benchmark. It trades about 0.13 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

RBC Sciences Current Valuation

Fairly Valued
Today
53.20
Please note that RBC Sciences' price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. RBC sciences biologiques owns a latest Real Value of C$52.59 per share. The recent price of the fund is C$53.2. We determine the value of RBC sciences biologiques from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we support taking in undervalued funds and trading overvalued funds since, in the future, fund prices and their ongoing real values will converge.
Since RBC Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RBC Fund. However, RBC Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  53.2 Real  52.59 Hype  53.2 Naive  52.71
The real value of RBC Fund, also known as its intrinsic value, is the underlying worth of RBC sciences biologiques Fund, which is reflected in its stock price. It is based on RBC Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of RBC Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
52.59
Real Value
53.57
Upside
Estimating the potential upside or downside of RBC sciences biologiques helps investors to forecast how RBC fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RBC Sciences more accurately as focusing exclusively on RBC Sciences' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
51.4653.0754.69
Details
Hype
Prediction
LowEstimatedHigh
52.2253.2054.18
Details
Naive
Forecast
LowNext ValueHigh
51.7352.7153.70
Details

RBC Sciences Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for RBC Sciences' investment risk. Standard deviation is the most common way to measure market volatility of funds, such as RBC sciences biologiques, and traders can use it to determine the average amount a RBC Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1282

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
Cash0P00007138Average RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 0.98
  actual daily
8
92% of assets are more volatile

Expected Return

 0.13
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average RBC Sciences is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RBC Sciences by adding it to a well-diversified portfolio.

RBC Sciences Fundamentals Growth

RBC Fund prices reflect investors' perceptions of the future prospects and financial health of RBC Sciences, and RBC Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RBC Fund performance.
Total Asset489.52 M

About RBC Sciences Performance

By analyzing RBC Sciences' fundamental ratios, stakeholders can gain valuable insights into RBC Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if RBC Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if RBC Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
To provide long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances. RBC Life is traded on Toronto Stock Exchange in Canada.

Things to note about RBC sciences biologiques performance evaluation

Checking the ongoing alerts about RBC Sciences for important developments is a great way to find new opportunities for your next move. Fund alerts and notifications screener for RBC sciences biologiques help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The fund holds 97.28% of its total net assets in equities
Evaluating RBC Sciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate RBC Sciences' fund performance include:
  • Analyzing RBC Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RBC Sciences' stock is overvalued or undervalued compared to its peers.
  • Examining RBC Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating RBC Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of RBC Sciences' management team can help you assess the Fund's leadership.
  • Pay attention to analyst opinions and ratings of RBC Sciences' fund. These opinions can provide insight into RBC Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating RBC Sciences' fund performance is not an exact science, and many factors can impact RBC Sciences' fund market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in RBC Fund

RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years